PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,000 | -8.6% | 600 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $35,000 | -23.9% | 600 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $46,000 | +27.8% | 600 | 0.0% | 0.01% | +40.0% |
| Q4 2021 | $36,000 | +5.9% | 600 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $34,000 | -5.6% | 600 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $36,000 | -14.3% | 600 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $42,000 | +16.7% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $36,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $36,000 | +16.1% | 600 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $31,000 | +55.0% | 600 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $20,000 | -25.9% | 600 | 0.0% | 0.01% | -36.4% |
| Q4 2019 | $27,000 | +17.4% | 600 | 0.0% | 0.01% | +37.5% |
| Q3 2019 | $23,000 | -11.5% | 600 | 0.0% | 0.01% | +14.3% |
| Q2 2019 | $26,000 | +13.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $23,000 | -11.5% | 600 | 0.0% | 0.01% | -22.2% |
| Q4 2018 | $26,000 | -10.3% | 600 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $29,000 | +52.6% | 600 | 0.0% | 0.01% | +28.6% |
| Q2 2018 | $19,000 | -86.8% | 600 | -87.0% | 0.01% | -86.5% |
| Q1 2018 | $144,000 | -31.8% | 4,618 | 0.0% | 0.05% | -28.8% |
| Q4 2017 | $211,000 | +27.1% | 4,618 | +4.5% | 0.07% | +35.2% |
| Q3 2017 | $166,000 | -22.1% | 4,418 | +10.0% | 0.05% | -34.1% |
| Q1 2016 | $213,000 | -31.1% | 4,018 | 0.0% | 0.08% | -28.7% |
| Q4 2015 | $309,000 | +106.0% | 4,018 | +9.8% | 0.12% | +49.4% |
| Q3 2015 | $150,000 | -39.3% | 3,658 | +4.8% | 0.08% | -15.4% |
| Q2 2015 | $247,000 | -13.0% | 3,490 | +8.9% | 0.09% | -26.0% |
| Q4 2014 | $284,000 | -11.0% | 3,205 | -2.7% | 0.12% | -37.6% |
| Q3 2014 | $319,000 | -24.4% | 3,295 | -28.2% | 0.20% | -24.8% |
| Q2 2014 | $422,000 | +31.5% | 4,590 | 0.0% | 0.26% | +15.9% |
| Q1 2014 | $321,000 | +30.0% | 4,590 | +6.9% | 0.23% | +26.3% |
| Q4 2013 | $247,000 | – | 4,295 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |